Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Anisha Mazloom"'
Autor:
Anisha Mazloom, MD, Stacey M. Sears, DNP, CPNP-AC, Erin F. Carlton, MD, MSc, Katherine E. Bates, MD, MSHP, Heidi R. Flori, MD
Publikováno v:
Critical Care Explorations, Vol 5, Iss 4, p e0906 (2023)
OBJECTIVES:. The 2020 pediatric Surviving Sepsis Campaign (pSSC) recommends measuring lactate during the first hour of resuscitation for severe sepsis/shock. We aimed to improve compliance with this recommendation for patients who develop severe seps
Externí odkaz:
https://doaj.org/article/5072abddd206450f8ecd23147ad6067c
Autor:
Wenchang Guo, Ruiwu Liu, Gaurav Bhardwaj, Ai-Hong Ma, Chun Changou, Joy C Yang, Yuanpei Li, Caihong Feng, Yan Luo, Anisha Mazloom, Eduardo Sanchez, Yan Wang, Wenzhe Huang, Randen Patterson, Christopher P Evans, Kit S Lam, Hsing-Jien Kung
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e70910 (2013)
Etk is a non-receptor tyrosine kinase, which provides a strong survival signal in human prostate cancer cells. Src, another tyrosine kinase that cross-activates with Etk, has been shown to play an important role in prostate cancer metastasis. Herein,
Externí odkaz:
https://doaj.org/article/847de7c6ffd142fb90d6021c6ca3066d
Publikováno v:
Critical Care Medicine. 50:631-631
Publikováno v:
Pediatrics. 144:160-160
Autor:
Yan Wang, Ruiwu Liu, Gaurav Bhardwaj, Chun A. Changou, Wenchang Guo, Randen L. Patterson, Christopher P. Evans, Ai Hong Ma, Joy C. Yang, Hsing Jien Kung, Caihong Feng, Wenzhe Huang, Yan Luo, Anisha Mazloom, Yuanpei Li, Eduardo Sanchez, Kit S. Lam
Publikováno v:
PloS one, vol 8, iss 8
PLoS ONE
PLoS ONE, Vol 8, Iss 8, p e70910 (2013)
PLoS ONE
PLoS ONE, Vol 8, Iss 8, p e70910 (2013)
Etk is a non-receptor tyrosine kinase, which provides a strong survival signal in human prostate cancer cells. Src, another tyrosine kinase that cross-activates with Etk, has been shown to play an important role in prostate cancer metastasis. Herein,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79c44d49f42a6b1c9ab14e9b8fb2762b
https://escholarship.org/uc/item/82g1r9sp
https://escholarship.org/uc/item/82g1r9sp
Autor:
Kai Xiao, Jinfan Yang, Eduardo Sanchez, Wenwu Xiao, Chun A. Changou, Sree V. Chintapalli, Ai-Hong Ma, Ruiwu Liu, Hsing Jien Kung, Randen L. Patterson, Wenchang Guo, Christopher P. Evans, Gaurav Bhardwaj, Pappanaicken R. Kumaresan, Kit S. Lam, Chi Tai Yeh, Anisha Mazloom
Publikováno v:
Cell death & disease, vol 5, iss 9
Cell Death & Disease
Cell Death & Disease
Btk and Etk/BMX are Tec-family non-receptor tyrosine kinases. Btk has previously been reported to be expressed primarily in B cells and has an important role in immune responses and B-cell malignancies. Etk has been shown previously to provide a stro
Abstract 368: Development of a highly potent and non-invasive optical imaging agent for glioblastoma
Autor:
Harry Tseng, Kit S. Lam, Ruiwu Liu, Yan-lei Liu, Wenwu Xiao, Fernanda C. Bononi, Anisha Mazloom, Eduardo Sanchez
Publikováno v:
Cancer Research. 72:368-368
Using the “one-bead one-compound” (OBOC) combinatorial library approach, we have previously identified a peptide ligand LXY1, cyclic c-d-G-L-G-Hyp-N-c, that targets the α3β1 integrin of U87MG glioblastoma cells. Very recently, we have further o
Autor:
Yan Wang, Yiyou Chen, Jixian Li, Ai-Hong Ma, Ruiwu Liu, Michelle Xia, Kit S. Lam, Wenzhe Huang, Eduardo Sanchez, Anisha Mazloom, Aimin Song, Chunping Xu, Jinying Ning, Wenchang Guo, Hsing Jien Kung
Publikováno v:
Cancer Research. 71:3580-3580
Itk (IL2-inducible T-cell kinase) is a non-receptor protein tyrosine kinase. It is selectively expressed in T cells, Mast cells, and NK cells. It plays an important role in T-cell maturation, proliferation, and malignancies. Using Western blotting, I
Autor:
Wenwu Xiao, Tianhong Li, Bononi, Fernanda, Lac, Diana, Kekessie, Ivy, Yanlei Liu, Sanchez, Eduardo, Anisha Mazloom, Ma, Ai-Hong, Lin, Jia, Tran, Jimmy, Yang, Kevin, Lam, Kit, Ruiwu Liu
Methods S1–S4. (DOCX 1572 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e115bdf3d549a1d425b21d151c17bde3
Autor:
Yan-lei Liu, Eduardo Sanchez, Kit S. Lam, Ivy A. Kekessie, Anisha Mazloom, Ai-Hong Ma, Ruiwu Liu, Diana Lac, Jimmy Tran, Jia Lin, Wenwu Xiao, Fernanda C. Bononi, Tianhong Li, Kevin Yang
Publikováno v:
EJNMMI Research
EJNMMI research, vol 6, iss 1
Xiao, W; Li, T; Bononi, FC; Lac, D; Kekessie, IA; Liu, Y; et al.(2016). Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of α3 integrin-expressing human tumors. EJNMMI Research, 6(1), 1-12. doi: 10.1186/s13550-016-0165-z. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/5tq4x0rx
EJNMMI research, vol 6, iss 1
Xiao, W; Li, T; Bononi, FC; Lac, D; Kekessie, IA; Liu, Y; et al.(2016). Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of α3 integrin-expressing human tumors. EJNMMI Research, 6(1), 1-12. doi: 10.1186/s13550-016-0165-z. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/5tq4x0rx
Background α3β1 integrin is overexpressed in several types of human cancer and is associated with poor prognosis, metastasis, and resistance to cancer treatment. We previously identified a cyclic peptide ligand LXY1 that specifically binds to the